A Prospective Intervention Phase I Study in Three Age De-escalating Group to Assess the Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2019
Price : $35 *
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 01 Apr 2019 Status changed from recruiting to completed.
- 12 Apr 2018 Status changed from not yet recruiting to recruiting.
- 14 Mar 2018 New trial record